Albany Molecular Research To Aquire Rival Cedarburg | March 31, 2014 Issue - Vol. 92 Issue 13 | Chemical & Engineering News
 
 
0
Facebook
Volume 92 Issue 13 | p. 7 | News of The Week
Issue Date: March 31, 2014 | Web Date: March 28, 2014

Albany Molecular Research To Aquire Rival Cedarburg

Move continues trend of consolidation in the pharmaceutical chemicals sector continues
Department: Business
Keywords: Acquisition, active pharmaceutical ingredients, contract manufacturing, services

Albany Molecular Research Inc. (AMRI) has agreed to acquire Cedarburg Hauser Pharmaceuticals, a Grafton, Wis.-based contract manufacturer of active pharmaceutical ingredients (APIs), for $41.0 million, including $2.8 million in debt. With the merger last year between Wisconsin-based Cambridge Major Laboratories and AAI Pharma Services, the deal marks the second recent purchase of a Midwest pharmaceutical chemical producer.

AMRI manufactures APIs in Rensselaer, N.Y., but in recent . . .

You Do Not Have Access to C&EN Protected Content.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society